Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Which Healthcare Mutual Fund Should You Buy: PRHSX or JNGLX?

By Zacks Investment ResearchStock MarketsJun 14, 2021 10:00PM ET
www.investing.com/analysis/which-healthcare-mutual-fund-should-you-buy-prhsx-or-jnglx-200586226
Which Healthcare Mutual Fund Should You Buy: PRHSX or JNGLX?
By Zacks Investment Research   |  Jun 14, 2021 10:00PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Many pharmaceutical companies also pay out regular dividends.

Companies that consistently offer dividends are financially stable and generate steady cash flows irrespective of market conditions. Mutual funds are the perfect choices for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.

In such circumstances, investing in healthcare mutual funds seems prudent. However, choosing the right mutual funds for your portfolio can be quite tricky. To that end, let us find out which of the two funds discussed below is better.

T. Rowe Price Health Sciences Fund PRHSX

This is a non-diversified fund that invests more than 80% of its assets in common stocks of companies engaged in various activities in the field of healthcare, medicine or life sciences. The fund mostly invests in mid- and large-capitalization companies.

This Sector-Health product has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the three and five-year benchmarks are 18.5% and 17%, respectively. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.

Meanwhile, as of the last filing, Thermo Fisher Scientific (NYSE:TMO) and Unitedhealth Group Inc were the top holdings for T. Rowe Price Health Sciences Fund.

This product, with a Zacks Mutual Fund Rank #1 (Strong Buy), was incepted in December 1995 and is managed by T. Rowe Price. PRHSX requires a minimal initial investment of $2,500.

Janus Henderson Global Life Sciences Fund Class D JNGLX

This fund aims for long-term capital growth. It invests the majority of its assets in securities of companies that the fund managers believe have a life science orientation. The fund also invests a minimum of 25% of its total assets in securities of companies from the "life sciences" sector.

This Sector-Health product has a history of positive total returns for over 10 years. Specifically, the fund’s returns are 16.5% over the three-year and 14.7% of the five-year period. To see how this fund performed compared in its category, and other #1 and 2 Ranked Mutual Funds, please click here.

Meanwhile, as of the last filing, Unitedhealth Group Inc and Astrazeneca Plc (LON:AZN) were the top holdings for Janus Henderson Global Life Sciences Fund Class D.

This product with a Zacks Mutual Fund Rank #1 (Strong Buy) was incepted in December 1998 and is managed by Janus Fund. JNGLX requires a minimal initial investment of $2,500.

To Conclude

While both PRHSX and JNGLX are buy-rated funds, upon having a closer look, we find that the former is a clear winner. PRHSX has a history of providing higher returns compared to JNGLX. Further, JNGLX has a 3-year beta of 0.80 compared to PRHSX’s 0.84. Moreover, JNGLX has a 3-year alpha of 1.88 compared to PRHSX’s 3.27.

Notably, a higher alpha indicates that managers of the particular fund, through careful stock selection, have been able to extract higher returns than the market. Therefore, for better returns one must opt for PRHSX.

Want key mutual fund info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Get Your Free (PRHSX): Fund Analysis Report

Get Your Free (JNGLX): Fund Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
Which Healthcare Mutual Fund Should You Buy: PRHSX or JNGLX?
 

Related Articles

Which Healthcare Mutual Fund Should You Buy: PRHSX or JNGLX?

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email